Pixabay/Deborah Breen Whiting
28 September 2020
A new study published in Journal of Clinical Medicine has explored why some patients have ocular hypertension but do not experience the degeneration associated with glaucoma.
Researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen found that patients with ocular hypertension but no glaucoma have increased antioxidant capacity and higher levels of anti-inflammatory, omega-3 derived chemical messengers.
The authors highlight: "The study opens avenues of therapeutic exploration, highlighting the significance of the omega-3 fatty acid chemical messengers' antioxidant capacity as a potential diagnostic biomarker and as a novel treatment to prevent glaucomatous neurodegeneration."
The researchers note that the study provides new insight into possible mechanisms of protection against oxidative stress in patients with ocular hypertension and may explain “the apparent tolerability” to increased intraocular pressure in these patients.
Researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen found that patients with ocular hypertension but no glaucoma have increased antioxidant capacity and higher levels of anti-inflammatory, omega-3 derived chemical messengers.
The authors highlight: "The study opens avenues of therapeutic exploration, highlighting the significance of the omega-3 fatty acid chemical messengers' antioxidant capacity as a potential diagnostic biomarker and as a novel treatment to prevent glaucomatous neurodegeneration."
The researchers note that the study provides new insight into possible mechanisms of protection against oxidative stress in patients with ocular hypertension and may explain “the apparent tolerability” to increased intraocular pressure in these patients.
Comments (1)
You must be logged in to join the discussion. Log in
Don Williams16 October 2020
I think all patients with OHT should be assessed for SLT
Report Like 190